The focus of this conference was survivorship but I did find
two posters that dealt with ovarian cancer survivorship in particular.
Impact of Chemotherapy-Induced
Neuropathy on Quality of Life Among Ovarian Cancer Survivors: Results from the
Population-Based Profiles Registry
This study was done in the Netherlands. I had the opportunity to speak directly to
Lonneke van de Poll-Franse, PhD one of the researchers . She told me that the
number of women diagnosed with ovarian cancer in the Netherlands was 800 just
slightly more than the number diagnosed each year in New Jersey. I thanked her
for doing research on a subject so important to ovarian cancer survivors. The
conclusion of the study as reported on the poster was that “Neuropathy symptoms
were experienced by 51% of women with ovarian cancer who receive chemotherapy
even up to 12 years after the end of treatment and seriously affect their
health related quality of life.”
The second study, done in the United States is an ongoing
GOG study. The GOG group is now part of NRG Oncology.
Baseline Characteristics of Ovarian
Cancer Survivors Enrolled in a Lifestyle Intervention Trial: Lives Study
The LIVES study
is recruiting women with stage II –IV ovarian cancer from 230 GOG
clinics. The study has recruited 20% of its goal . Women were randomized to the
lifestyle intervention group or the control group. In the lifestyle group the womenwill receive information about healthy lifestyle and
nutrition and is delivered via the internet using a special interactive
platform. More information can be found at http://ovarianlives.org/
Dee
Every Day is a Blessing!
No comments:
Post a Comment